title: Targeted kinase inhibitors in lung cancer: from EGFR to patients.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Apolone
authors.forename: Carlo
authors.initials: C
authors.lastname: La Vecchia
authors.forename: Silvio
authors.initials: S
authors.lastname: Garattini
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D066246:ErbB Receptors / Q000378:metabolism*; D000069347:Erlotinib Hydrochloride; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use
chemical_list: D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors; D000077156:Gefitinib